All Relations between Paroxetine and serotonin

Publication Sentence Publish Date Extraction Date Species
Mark Mille. Depression after cardiac transplant treated with interpersonal psychotherapy and paroxetine. American journal of psychotherapy. vol 56. issue 4. 2003-04-18. PMID:12520890. the patient was prescribed the selective serotonin reuptake inhibitor paroxetine and began interpersonal psychotherapy. 2003-04-18 2023-08-12 Not clear
E Hernández, S Lastra, M Urbina, I Carreira, L Lim. Serotonin, 5-hydroxyindoleacetic acid and serotonin transporter in blood peripheral lymphocytes of patients with generalized anxiety disorder. International immunopharmacology. vol 2. issue 7. 2003-04-15. PMID:12188031. since serotonin transporter is a marker of peripheral blood lymphocytes and it is modified in major depression, the aim of the present work was to evaluate this transporter by the binding of [3h]paroxetine to membrane preparations of blood peripheral lymphocytes from control subjects and patients with generalized anxiety disorder. 2003-04-15 2023-08-12 human
James M Ferguson, Keith A Wesnes, Gerri E Schwart. Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients. International clinical psychopharmacology. vol 18. issue 1. 2003-04-15. PMID:12490769. we report an assessment of the effects of the selective norepinephrine reuptake inhibitor reboxetine, the selective serotonin reuptake inhibitor paroxetine, and placebo on a variety of measures of cognitive functioning in patients with mdd. 2003-04-15 2023-08-12 Not clear
Shaila Misri, Xanthoula Kostara. Benefits and risks to mother and infant of drug treatment for postnatal depression. Drug safety. vol 25. issue 13. 2003-04-11. PMID:12381212. the article will specifically focus on the use of fluoxetine, sertraline, paroxetine, fluvoxamine and citalopram, which are more commonly used and belong to the selective serotonin reuptake inhibitor group of antidepressants. 2003-04-11 2023-08-12 Not clear
Francesca Fernandez, Sophie Sarre, Jean-Marie Launay, Sylvie Aguerre, Véronique Guyonnet-Dupérat, Marie-Pierre Moisan, Guy Ebinger, Yvette Michotte, Pierre Mormède, Francis Chaoulof. Rat strain differences in peripheral and central serotonin transporter protein expression and function. The European journal of neuroscience. vol 17. issue 3. 2003-04-10. PMID:12581167. midbrain and hippocampal [3h]paroxetine binding at the 5-htt and hippocampal [3h]serotonin (5-ht) reuptake were increased in male and female f344 rats, compared to their lew counterparts, these strain differences being observed both in rats of commercial origin and in homebred rats. 2003-04-10 2023-08-12 human
Francesca Fernandez, Sophie Sarre, Jean-Marie Launay, Sylvie Aguerre, Véronique Guyonnet-Dupérat, Marie-Pierre Moisan, Guy Ebinger, Yvette Michotte, Pierre Mormède, Francis Chaoulof. Rat strain differences in peripheral and central serotonin transporter protein expression and function. The European journal of neuroscience. vol 17. issue 3. 2003-04-10. PMID:12581167. saturation studies of midbrain and hippocampal [3h]paroxetine binding at the 5-htt, and hippocampal and blood platelet [3h]5-ht reuptake, also revealed significant strain differences in bmax and vmax values. 2003-04-10 2023-08-12 human
Francesca Fernandez, Sophie Sarre, Jean-Marie Launay, Sylvie Aguerre, Véronique Guyonnet-Dupérat, Marie-Pierre Moisan, Guy Ebinger, Yvette Michotte, Pierre Mormède, Francis Chaoulof. Rat strain differences in peripheral and central serotonin transporter protein expression and function. The European journal of neuroscience. vol 17. issue 3. 2003-04-10. PMID:12581167. although f344 and lew rats differ in the activity of the hypothalamo-pituitary-adrenal (hpa) axis, manipulations of that axis revealed that the strain differences in hippocampal [3h]paroxetine binding at 5-htts and [3h]5-ht reuptake were not accounted for by corticosteroids. 2003-04-10 2023-08-12 human
Jeroen A J Schmitt, Johannes G Ramaekers, Monique J Kruizinga, Martin P J van Boxtel, Eric F P M Vuurman, Wim J Riede. Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man. Journal of psychopharmacology (Oxford, England). vol 16. issue 3. 2003-04-07. PMID:12236626. in the present study, we investigated the putative role of serotonergic-dopaminergic interactions in diminished vigilance by comparing the attentional effects of sertraline, a selective serotonin reuptake inhibitor (ssri) with additional mild dopamine stimulating effects, with those of paroxetine, a ssri without dopamine activity, using a placebo-controlled, double-blind, three-way cross-over design. 2003-04-07 2023-08-12 human
Pilar Rosel, Belén Arranz, Mikel Urretavizcaya, Miguel Oros, Luis San, Julio Vallejo, Miguel Angel Navarr. Different distributions of the 5-HT reuptake complex and the postsynaptic 5-HT(2A) receptors in Brodmann areas and brain hemispheres. Psychiatry research. vol 111. issue 2-3. 2003-04-07. PMID:12374628. in cingulate cortex, the highest [3h]imipramine and [3h]paroxetine b(max) values were noted in brodmann area 33 followed by area 24, while postsynaptic 5-ht(2a) receptors were mainly distributed through brodmann areas 23 and 29. 2003-04-07 2023-08-12 human
Danusa Dias Soares, Francesca Fernandez, Sylvie Aguerre, Aline Foury, Pierre Mormède, Francis Chaoulof. Fox odour affects corticosterone release but not hippocampal serotonin reuptake and open field behaviour in rats. Brain research. vol 961. issue 1. 2003-04-01. PMID:12535790. when group-housed sd rats were tested 1 week after a 1-h exposure to tmt, hippocampal 5-ht metabolism, [3h]5-ht reuptake, and [3h]paroxetine binding at the 5-ht transporter remained unchanged. 2003-04-01 2023-08-12 rat
b' Shanaz Tejani-Butt, Joseph Kluczynski, William P Par\\xc3\\xa. Strain-dependent modification of behavior following antidepressant treatment. Progress in neuro-psychopharmacology & biological psychiatry. vol 27. issue 1. 2003-04-01. PMID:12551720.' rats were treated with desipramine (norepinephrine [ne] uptake blocker), nomifensine (ne and dopamine [da] uptake blocker), paroxetine (serotonin [5-ht] uptake blocker) or saline, for 12 days. 2003-04-01 2023-08-12 rat
Jeffrey S McCombs, Lizheng Shi, Glen L Stimmel, Thomas W Crogha. A retrospective analysis of the revocation of prior authorization restrictions and the use of antidepressant medications for treating major depressive disorder. Clinical therapeutics. vol 24. issue 11. 2003-03-31. PMID:12501884. the california medicaid (medi-cal) program removed prior authorization restrictions for 2 selective serotonin reuptake inhibitors (ssris), fluoxetine and paroxetine, in may 1996. 2003-03-31 2023-08-12 Not clear
Melissa P Piasecki, David O Antonuccio, Gerri M Steinagel, Barbara S Kohlenberg, Karen Kapada. Penetrating the blind in a study of an SSRI. Journal of behavior therapy and experimental psychiatry. vol 33. issue 2. 2003-03-21. PMID:12472171. we conclude that the blind may unwittingly be broken when the treatments under study are placebo and the selective serotonin reuptake inhibitor (ssri) paroxetine. 2003-03-21 2023-08-12 human
Kathryn S Richards, David J Simon, Stefan R Pulver, Barbara S Beltz, Eve Marde. Serotonin in the developing stomatogastric system of the lobster, Homarus americanus. Journal of neurobiology. vol 54. issue 2. 2003-03-14. PMID:12500313. serotonin uptake was blocked by paroxetine and 0% na(+) saline. 2003-03-14 2023-08-12 lobster
D Gervasoni, E Panconi, V Henninot, R Boissard, B Barbagli, P Fort, P H Lupp. Effect of chronic treatment with milnacipran on sleep architecture in rats compared with paroxetine and imipramine. Pharmacology, biochemistry, and behavior. vol 73. issue 3. 2003-02-13. PMID:12151030. the effect of a new selective serotonin and noradrenaline reuptake inhibiting (snri) antidepressant, milnacipran, on rem sleep has been investigated and compared with that of the ssri, paroxetine, and the tricyclic, imipramine. 2003-02-13 2023-08-12 rat
Karl Rickels, Moira Ryn. Pharmacotherapy of generalized anxiety disorder. The Journal of clinical psychiatry. vol 63 Suppl 14. 2003-02-11. PMID:12562113. the extended-release formulation of venlafaxine and selective serotonin reuptake inhibitors such as paroxetine and sertraline are also efficacious in gad. 2003-02-11 2023-08-12 Not clear
Suparporn Muchimapura, Robert Mason, Charles A Marsde. Effect of isolation rearing on pre- and post-synaptic serotonergic function in the rat dorsal hippocampus. Synapse (New York, N.Y.). vol 47. issue 3. 2003-02-04. PMID:12494403. uptake studies using (3)[h]5-ht, however, found no change in the inhibition of uptake produced by either fluoxetine or paroxetine in isolation compared to group-reared rats. 2003-02-04 2023-08-12 human
Dorotea Mück-Seler, Nela Pivac, Marina Sagud, Miro Jakovljević, Alma Mihaljević-Pele. The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression. Progress in neuro-psychopharmacology & biological psychiatry. vol 26. issue 7-8. 2003-01-27. PMID:12502009. peripheral biochemical markers, platelet and serum 5-ht concentrations, platelet monoamine oxidase (mao) activity, plasma levels of cortisol and prolactin (prl), were investigated in patients with major depression before and after 4 weeks of treatment with paroxetine (an inhibitor of 5-ht uptake) or tianeptine (a stimulator of 5-ht uptake). 2003-01-27 2023-08-12 Not clear
Dorotea Mück-Seler, Nela Pivac, Marina Sagud, Miro Jakovljević, Alma Mihaljević-Pele. The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression. Progress in neuro-psychopharmacology & biological psychiatry. vol 26. issue 7-8. 2003-01-27. PMID:12502009. paroxetine treatment induced significant decrease in platelet 5-ht concentrations in both responders and nonresponders, while no alterations in platelet 5-ht values were found in tianeptine-treated patients. 2003-01-27 2023-08-12 Not clear
Dorotea Mück-Seler, Nela Pivac, Marina Sagud, Miro Jakovljević, Alma Mihaljević-Pele. The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression. Progress in neuro-psychopharmacology & biological psychiatry. vol 26. issue 7-8. 2003-01-27. PMID:12502009. there was a subgroup of depressed patients in paroxetine-treated group with high pretreatment platelet 5-ht concentration and later poor therapeutic response to paroxetine treatment. 2003-01-27 2023-08-12 Not clear